63
In band
Moving averages
SMA 200$56.20+19.23%
Company profile
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$129.94B
P/E ratio14.01
EPS$4.54
Beta0.225
Dividend yield3.87%
52-week high$68.10
52-week low$41.13
Similar stocks in Drug Manufacturers - General
RSI alerts for BMY
Get an email the moment Bristol-Myers Squibb Company crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 1:12 AM EDT